NEW YORK (360Dx)- With a new 8,000 square-foot laboratory in Rolle, Switzerland, NeoGenomics plans to precisely replicate the full spectrum of specialty oncology lab services that the company offers through its six labs in the United States.

The goal is to be able to offer pharmaceutical clients who work with NeoGeonomic for cancer drug and diagnostics development a process that is consistent across the US and Europe, executives said.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.